US patent for simple, low-cost nucleic acid test:
This article was originally published in Clinica
Executive Summary
Molecular Innovations has received a US patent covering its portable, easy-to-use, self-contained system for isolating, amplifying and sequencing DNA or RNA. The system, which can be used to detect specific nucleic acid sequences corresponding to genetically-linked diseases, may provide an economical and simple point-of-care tool for detecting disease predisposition and for monitoring patient response to treatment. The device could overcome the cost and ease-of-use hurdles of transferring nucleic acid-based testing to routine clinical or field testing faced by other methods currently used for genetic testing, said the Denver, Colorado-based company.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.